SWTX logo

SpringWorks Therapeutics (SWTX) Company Overview

Profile

Full Name:

SpringWorks Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 13, 2019

Indexes:

Not included

Description:

SpringWorks Therapeutics, Inc. is a biopharmaceutical company operating in the clinical stage. The company is focused on acquiring, developing, and commercializing medicines for patients suffering from rare diseases and oncological diseases. The company has a portfolio of oncology product candidates targeting small molecules, and other programs aimed at treating genetically defined types of cancer. It provides nirogacestat, which is an oral small molecule gamma-secretase inhibitor (GSI). It also provides mirdametinib, which is an oral low molecular weight MEK inhibitor. Mirdametinib is being developed for the treatment of plexiform neurofibromas associated with neurofibromatosis type 1 (NF1-PN). SpringWorks Therapeutics, Inc. was founded in 2017, with its headquarters located in Stamford, Connecticut.

Events Calendar

Earnings

Next earnings date:

Feb 20, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 12, 25 Wedbush
Outperform
Feb 12, 25 HC Wainwright & Co.
Buy
Feb 12, 25 Evercore ISI Group
Outperform
Jan 8, 25 Guggenheim
Buy
Nov 20, 24 Evercore ISI Group
Outperform
Nov 12, 24 HC Wainwright & Co.
Buy
Sep 4, 24 JP Morgan
Overweight
Aug 28, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
May 31, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for SpringWorks Therapeutics?
  • Does SpringWorks Therapeutics pay dividends?
  • What sector is SpringWorks Therapeutics in?
  • What industry is SpringWorks Therapeutics in?
  • What country is SpringWorks Therapeutics based in?
  • When did SpringWorks Therapeutics go public?
  • Is SpringWorks Therapeutics in the S&P 500?
  • Is SpringWorks Therapeutics in the NASDAQ 100?
  • Is SpringWorks Therapeutics in the Dow Jones?
  • When was SpringWorks Therapeutics's last earnings report?
  • When does SpringWorks Therapeutics report earnings?
  • Should I buy SpringWorks Therapeutics stock now?

What is the ticker symbol for SpringWorks Therapeutics?

The ticker symbol for SpringWorks Therapeutics is NASDAQ:SWTX

Does SpringWorks Therapeutics pay dividends?

No, SpringWorks Therapeutics does not pay dividends

What sector is SpringWorks Therapeutics in?

SpringWorks Therapeutics is in the Healthcare sector

What industry is SpringWorks Therapeutics in?

SpringWorks Therapeutics is in the Biotechnology industry

What country is SpringWorks Therapeutics based in?

SpringWorks Therapeutics is headquartered in United States

When did SpringWorks Therapeutics go public?

SpringWorks Therapeutics's initial public offering (IPO) was on September 13, 2019

Is SpringWorks Therapeutics in the S&P 500?

No, SpringWorks Therapeutics is not included in the S&P 500 index

Is SpringWorks Therapeutics in the NASDAQ 100?

No, SpringWorks Therapeutics is not included in the NASDAQ 100 index

Is SpringWorks Therapeutics in the Dow Jones?

No, SpringWorks Therapeutics is not included in the Dow Jones index

When was SpringWorks Therapeutics's last earnings report?

SpringWorks Therapeutics's most recent earnings report was on Nov 12, 2024

When does SpringWorks Therapeutics report earnings?

The next expected earnings date for SpringWorks Therapeutics is Feb 20, 2025

Should I buy SpringWorks Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions